Raising funds for business expansion through a public offering
First written in FY2018-Q3. 13 of 15 entries say "Advanced", first in FY2019-Q1. Latest entry: FY2022-Q2.
No other company in this theme has enough history to compare yet.
- FY2022-Q2AdvancedAnnual report
「Proceeds from the issuance of shares through the exercise of stock acquisition rights: ¥4.500 million」
During the cumulative second-quarter consolidated period, the Company recorded ¥4.500 million in proceeds from the issuance of shares through the exercise of stock acquisition rights. - FY2022-Q1AdvancedAnnual report
「1 October 2021–31 December 2021 (Note) 10,000 10,734,200 2,250 561,787 2,250 1,371,787 (Note) The increase was due to the exercise of stock acquisition rights.」
In the first quarter, 10,000 shares were issued through the exercise of stock acquisition rights, increasing stated capital and the capital reserve by ¥2.250 million each. - FY2021AdvancedAnnual report
「29 October 2020–23 March 2021 4,000 10,724,200 900 559,537 900 1,369,537 (Note) The increase was due to the exercise of stock acquisition rights.」
The exercise of stock acquisition rights resulted in the issuance of 4,000 shares and increases of ¥900,000 each in stated capital and the capital reserve. - FY2021-Q2AdvancedAnnual report
「1 January 2021–31 March 2021 2,000 10,724,200 450 559,537 450 1,369,537 (Note) The increase was due to the exercise of stock acquisition rights.」
In the second quarter, 2,000 shares were issued through the exercise of stock acquisition rights, increasing stated capital and the capital reserve by ¥450,000 each. - FY2021-Q1AdvancedAnnual report
「1 October 2020–31 December 2020 (Note) 2,000 10,722,200 450 559,087 450 1,369,087 (Note) The increase was due to the exercise of stock acquisition rights.」
In the first quarter, 2,000 shares were issued through the exercise of stock acquisition rights, increasing stated capital and the capital reserve by ¥450,000 each. - FY2020AdvancedAnnual report
「The increase of 392,400 shares was due to the exercise of the First, Second and Third Series of Stock Acquisition Rights.」
During the fiscal year, 392,400 shares were issued through the exercise of stock acquisition rights, increasing stated capital and the capital reserve by ¥61.594 million each. - FY2020-Q3AdvancedAnnual report
「1 April 2020–30 June 2020 4,000 10,357,800 900 502,253 900 1,312,253 (Note) The increase was due to the exercise of stock acquisition rights.」
In the third quarter, 4,000 shares were issued through the exercise of stock acquisition rights, increasing stated capital and the capital reserve by ¥900,000 each. - FY2020-Q2AdvancedAnnual report
「1 January 2020–31 March 2020 2,000 10,353,800 450 501,353 450 1,311,353 (Note) The increase was due to the exercise of stock acquisition rights.」
In the second quarter, 2,000 shares were issued through the exercise of stock acquisition rights, increasing stated capital and the capital reserve by ¥450,000 each. - FY2020-Q1AdvancedAnnual report
「1 October 2019–31 December 2019 (Note) 24,000 10,351,800 3,861 500,903 3,861 1,310,903 (Note) The increase was due to the exercise of stock acquisition rights.」
In the first quarter, 24,000 shares were issued through the exercise of stock acquisition rights, increasing stated capital and the capital reserve by ¥3.861 million each. - FY2019AdvancedAnnual report
「24 October 2018–19 August 2019 (Note 10) 133,700 2019年9月10日 (Note 10) 4,000 (Note) The increase was due to the exercise of stock acquisition rights.」
The exercise of stock acquisition rights resulted in additional increases in the number of shares issued, stated capital and the capital reserve during the fiscal year. - FY2019-Q3AdvancedAnnual report
「1 April 2019–30 June 2019 6,000 5,151,900 1,776 493,488 1,776 1,303,488 (Note) The increase was due to the exercise of stock acquisition rights.」
In the third quarter, 6,000 shares were issued through the exercise of stock acquisition rights, increasing stated capital and the capital reserve by ¥1.776 million each. - FY2019-Q2AdvancedAnnual report
「1 January 2019–31 March 2019 (Note) 109,500 5,145,900 32,430 491,711 32,430 1,301,711 (Note) 1. The increase was due to the exercise of stock acquisition rights.」
In the second quarter, 109,500 shares were issued through the exercise of stock acquisition rights, increasing stated capital and the capital reserve by ¥32.430 million each. The Company also reports the issuance of 6,000 shares and an increase of ¥1.776 million each in stated capital and the capital reserve in April 2019. - FY2019-Q1AdvancedAnnual report
「1 October 2018–31 December 2018 (Note) 8,200 5,036,400 2,428 459,281 2,428 1,269,281 (Note) The increase was due to the exercise of stock acquisition rights.」
In the first quarter, 8,200 shares were issued through the exercise of stock acquisition rights, increasing stated capital and the capital reserve by ¥2.428 million each. - FY2018RestatedAnnual report
「4 July 2018 Paid public offering (offering through the book-building method) Issue price ¥1,180 Underwriting price ¥1,085.60」
The Company discloses the funds raised through the public offering accompanying its listing and subsequent exercises of stock acquisition rights in the annual changes in the number of shares and stated capital. - FY2018-Q3First statedAnnual report
「At meetings of the Board of Directors held on 1 June 2018 and 15 June 2018, the Company resolved to issue new shares as described below, and payment was completed on 4 July 2018.」
The Company conducted a public offering of 200,000 common shares, raising total underwriting proceeds of ¥217.120 million.